The US Food and Drug Administration (FDA) has granted Fast Track designation for Eli Lilly and Company’s tirzepatide to treat adults with obesity or overweight with weight-associated comorbidities. On holding talks with the regulatory agency, the company intends to...
Surrozen and Boehringer Ingelheim have entered a partnership and licence agreement for researching and developing SZN-413 to treat retinal diseases. The collaboration will merge the SWAP technology of Surrozen for Wnt signalling modulation with the research and...
Nested Therapeutics uses computational techniques to map mutations and protein structures, identifying previously unseen places where a cancer drug can bind. The Versant Ventures-founded startup is now out of stealth with two programs on the path to the clinic.
